ProfileGDS4718 / 1555822_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 35% 33% 29% 38% 34% 24% 38% 36% 29% 32% 39% 30% 29% 29% 27% 30% 31% 29% 26% 36% 37% 32% 37% 35% 37% 29% 33% 26% 30% 33% 29% 25% 32% 35% 30% 29% 30% 33% 34% 34% 30% 31% 29% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7779835
GSM549102patient 115, normal, homogenized [OPG study]4.6886333
GSM549104patient 119, normal, homogenized [OPG study]4.4899429
GSM549108patient 138, normal, homogenized [OPG study]4.9471138
GSM549119patient 077, normal, homogenized [OPG study]4.7213734
GSM549133patient 032, cancer, homogenized [OPG study]4.2609224
GSM549139patient 042, cancer, homogenized [OPG study]4.863538
GSM549099patient 107, normal, homogenized [OPG study]4.832136
GSM549109patient 139, normal, homogenized [OPG study]4.5400229
GSM549110patient 046, normal, homogenized [OPG study]4.6325532
GSM549114patient 063, normal, homogenized [OPG study]4.881139
GSM549122patient 082, normal, homogenized [OPG study]4.5711830
GSM549134patient 033, cancer, homogenized [OPG study]4.4907229
GSM549136patient 036, cancer, homogenized [OPG study]4.4492329
GSM549140patient 044, cancer, homogenized [OPG study]4.3845227
GSM549111patient 047, normal, homogenized [OPG study]4.5302630
GSM549113patient 057, normal, homogenized [OPG study]4.5241231
GSM549132patient 031, cancer, homogenized [OPG study]4.4796729
GSM549137patient 038, cancer, homogenized [OPG study]4.3485326
GSM549142patient 047, cancer, homogenized [OPG study]4.9231836
GSM549100patient 110, normal, homogenized [OPG study]4.8963237
GSM549107patient 135, normal, homogenized [OPG study]4.5956632
GSM549115patient 068, normal, homogenized [OPG study]4.8090437
GSM549116patient 072, normal, homogenized [OPG study]4.7229235
GSM549120patient 078, normal, homogenized [OPG study]4.8257237
GSM549131patient 030, cancer, homogenized [OPG study]4.4442529
GSM549118patient 074, normal, homogenized [OPG study]4.6552633
GSM549129patient 027, cancer, homogenized [OPG study]4.3971226
GSM549123patient 088, normal, homogenized [OPG study]4.5252630
GSM549124patient 006, cancer, homogenized [OPG study]4.7032433
GSM549126patient 015, cancer, homogenized [OPG study]4.4999129
GSM549128patient 025, cancer, homogenized [OPG study]4.3036325
GSM549103patient 117, normal, homogenized [OPG study]4.6964532
GSM549117patient 073, normal, homogenized [OPG study]4.7147135
GSM549138patient 041, cancer, homogenized [OPG study]4.5133730
GSM549141patient 045, cancer, homogenized [OPG study]4.4424329
GSM549130patient 028, cancer, homogenized [OPG study]4.5609330
GSM549101patient 111, normal, homogenized [OPG study]4.7182433
GSM549105patient 128, normal, homogenized [OPG study]4.758534
GSM549106patient 134, normal, homogenized [OPG study]4.6509934
GSM549112patient 048, normal, homogenized [OPG study]4.5387930
GSM549125patient 011, cancer, homogenized [OPG study]4.5812131
GSM549127patient 024, cancer, homogenized [OPG study]4.4633229
GSM549135patient 035, cancer, homogenized [OPG study]4.3912128